PDD
7
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
43%
3 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders
Cord Blood Infusion for Children With Autism Spectrum Disorder
Photodynamic Diagnosis (PDD) in Flexible Cystoscopy
Variance of Video Games Playing Patterns Among Adolescents With Psychiatric Disorders
An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum